The synthesis of cyclic peptoids containing an indole hydrophobic scaffold has been realised through the ringclosing metathesis of diallylated precursors. The precursors and their cyclic counterparts possessed poor antibacterial activity in contrast to previously reported cyclic peptoids containing hydrophobic scaffolds. 
Introduction
The development and clinical application of antibiotics in the late 1930's enabled the control of the majority of bacterial infections. However, by the late 1950's up to 85% of clinical staphylococci isolates were found to be penicillin resistant. 1 Bacteria now have the ability to pass genetic information onto different strains leading to the widespread resistance of bacteria to many of the currently used antibiotics. The recent report of resistance to vancomycin is of the greatest concern as it represents the last line of defence against infections of multidrug resistant staphylococci and enterococci. 2 Resistance to vancomycin was first documented in 1988, 3 from hospitals in both Europe, 4 and the USA. 5 This emergence of vancomycin resistant enterococci (VRE) is significant and points to the prospect of widespread vancomycin resistance to multi-drug resistant pathogenic bacteria such as methicillin resistant Staphylococcus aureus (MRSA). 'Super-resistant' bacterial strains such as these have been demonstrated in a controlled environment, highlighting the ease in which resistance may spread to pathogenic bacteria, 3 and there are now cases of fully resistant isolates of Staphyloccocus aureus being reported. 6 The advent of untreatable multidrug resistant bacteria has created an unmet medical need to create new antibacterial agents. The development of new therapeutic agents is even more critical considering only one new class of antibacterial agents, the oxazolidinone linezolid, 7 has been launched in the last 35 years, and already resistance to this therapeutic has started to emerge. [8] [9] [10] With the increasing spread of antibacterial resistance, including resistance by pathogenic bacteria to vancomycin, there is a compelling imperative for new antibacterials. 10 We have undertaken a program investigating the design and synthesis of cyclic peptoids linked by a hydrophobic scaffold as potential antibacterial agents, and thus far, have shown the binaphthyl 11 and carbazole scaffolds 12, 13 within these cyclic peptoids produce antibacterial agents, for example 1 and 2, of reasonable potency ( Figure 1 ).
Therefore, as part of this programme targeting the design and synthesis of new peptoid derivatives as antibacterial agents and attempting to address the resistance mechanism against vancomycin, we investigated the synthesis of some acyclic and cyclic indole-based derivatives. These derivatives were designed to explore the effect on activity of a smaller rigid scaffold in which the indolic nitrogen was to serve as one of the anchor points. The results are reported in this paper. . Cyclic peptoids containing a hydrophobic scaffold that show anti-bacterial activity. 11-13 MIC = minimum inhibitory concentration and activities are against a wild type S. aureus strain.
Results and Discussion

Synthesis of Indole-Based Peptoids
The synthesis of cyclic peptoids incorporating an indolic scaffold is outlined in Scheme 1. The strategy involved the addition of a dipeptide to an indole unit that contained a linking group at C3 as well as utilising the N1 position as a linking group via the addition of an allyl substituent. Cyclisation was to be achieved using reliable ring-closing metathesis (RCM) reactions. [11] [12] [13] [14] While the choice of dipeptide to use is potentially extensive, a limitation is that one of the amino acids must also contain an additional allyl group such that the ring-closing metathesis reaction is possible. Cyclic peptoids of different sizes were synthesised by extending the number of methylene linkers between the indole C3 position and the first carboxylic acid unit.
Therefore, treatment of commercially available indole acids 3-5 with base, followed by an excess of allyl bromide gave a mixture of both the allyl esters 9-11 and the diallylated products 6-8 (Scheme 1).
Subsequent saponification with LiOH yielded the desired carboxylic acids 12-14. This 2-step process was the most efficient method of N-allylation in the presence of the carboxylic acid, although with the lengthening of the C3 chain, the yield of the monoallyl ester byproducts, 10 and 11, became more prominent. The coupling of the dipeptide, L-allylGlyOMe-D-Lys 15, to 12-14 was achieved through well established EDCI coupling. The key RCM of dienes 16-18 proceeded efficiently in the case of the products 19-21 producing a discernible mixture of both E and Z isomers, which could not be separated by silica gel chromatography. In contrast, the yield of 21 was lower, presumably due to the difficulties in forming the larger ring. However, further optimisation of this reaction may improve this outcome. The structures of the cyclised products were elucidated on the basis of high resolution mass spectrometric and NMR spectroscopic evidence. In the 1 H-NMR spectrum of 19, for example, the signal ascribed to The corresponding hydrochloride salts of the deprotected acyclic precursors (25-27) were also synthesised using typical acidic conditions starting from 15-17 (Scheme 2). Further, the corresponding guanidine derivatives of the cyclic peptoids 31-33 were also produced via 28-30, again using standard reaction conditions starting from 22-24, and using N,N′-diBoc-N-triflylguanidine in the key guanidation step (Scheme 3). The chemical yields for all transformations were not optimised, leading to some inconsistencies in outcome for individual steps. However, the ease of formation of all derivatives ensured facile access to the desired cyclic derivatives for testing.
Antibacterial Results
The synthesised cyclic dipeptoids 22-24 and 31-33 were tested against the Gram-positive bacterium S.
aureus ATCC6538 and showed MIC values greater than ≥ 125 μg/mL, indicating that these indole-based scaffolds are not good hydrophobic units for incorporation into the design program for antibacterial development. In view of the success of some of our previous cyclic peptoid structures that showed antibacterial activities of MIC 7 μg/mL and 15 μg/mL for 1 and 2, respectively (Figure 1 ), the biological results for the new indole-based molecules were disappointing. The binaphthyl scaffold would contain a degree of flexibility by comparison, and might be able to orientate more easily into an active conformation. However, the carbazole scaffold in 2 is quite rigid, a conformational characteristic which is anticipated to be closer to that shown by the indole-based molecules. Although the mode of action of this class of compounds has not yet been established, we anticipate that the lack of activity for the new derivatives must arise from the wrong 3-dimensional array of the relevant substituents. The smaller macrocyclic ring sizes in 22-24 compared with those in 1 or 2 may also be relevant in this context.
Given that the same dipeptide is used in all three cases, we therefore presume that the presence of a particular hydrophobic moiety becomes an additional important element in establishing antibacterial activity, and that the indole scaffold itself is simply not appropriate. We are currently investigating other hydrophobic scaffolds in order to improve antibacterial activity.
Experimental
General
All NMR spectra were determined in CDCl 3 
Allyl 1-allyl-1H-indole-3-butanoate (8) and allyl 1H-indole-3-butanoate (11)
These were prepared by general procedure A using 1H-indole-3-butanoic acid 5 (1.00 g, 4.9 mmol), NaH (217 mg, 5.4 mg), allyl bromide (1.1 mL, 12.7 mmol) and DMF (6 mL). The crude product was subjected to flash silica gel column chromatography (50% DCM in petroleum spirit) to give 8 (0.46 g, 33%) as an oil. TLC (petroleum spirit/DCM 2: 
Hydrolysis of Allyl Esters -General Procedure B 1-Allyl-1H-indole-3-acetic acid (12)
To a solution of 6 (1.84 g, 7.2 mmol) in THF/water (5:2, 35 mL) was added lithium hydroxide (0.3 g, 12.5 mmol) and the reaction mixture was placed in an ice bath and stirred at 0 °C for 3 h. It was then concentrated and the residue was partitioned between diethyl ether and water (2 x 30 mL). The combined aqueous layers were acidified with HCl (10%) to pH < 2. The aqueous layer was then saturated with sodium chloride and extracted with DCM (20 mL), dried (Na 2 SO 4 ) and evaporated to give 
1-Allyl-1H-indole-3-propanoic acid (13)
This was prepared by general procedure B from 7 (0.650 g, 2.4 mmol), LiOH (0.220 g, 9.2 mmol) and 
1-Allyl-1H-indole-3-butanoic acid (14)
This was prepared by general procedure B from 8 (0. 
Preparation of Methyl (2S,5R)-2-Allyl-5-amino-3-aza-9-(tert-butoxycarbonyl)amino-4-oxononanoate -L-allylGlyOMe-D-Lys (15)
To a mixture of N-Fmoc-D-Lys(Boc)OH (1.22 g, 2.61 mmol), methyl (S)-2-amino-4-pentenoate hydrochloride (430 mg, 2.61 mmol) and 4-dimethylaminopyridine (DMAP) (1 crystal) was added dry DCM (10 mL) followed by N,N-diisopropylethylamine (0.45 mL, 2.61 mmol) under a nitrogen atmosphere. The mixture was stirred at rt for 5 min before EDCI (500 mg, 2.61 mmol) was added, and the reaction mixture was then stirred for 23.5 h. After this period, the reaction mixture was diluted with DCM, washed with brine and then water, and the DCM layer was dried and evaporated. 
Methyl (2S,5R)-2-allyl-10-(N-allyl-1H-indol-3-yl)-3,6-diaza-5-(tert-butoxycarbonylamino)butyl-4,7-dioxodecanoate (18)
This was prepared by general procedure C using 14 (0. 
Amino Acid Deprotection -General Procedure D.
Methyl (2S,5R)-2-allyl-8-(N-allyl-1H-indol-3-yl)-3,6-diaza-5-(4-aminobutyl)-4,7-dioxooctanoate hydrochloride (25)
To a solution of 16 (0.07 g, 0.1 mmol) in DCM (2 mL) was added trifluoroacetic acid (2 mL 
Methyl (2S,5R)-2-allyl-9-(N-allyl-1H-indol-3-yl)-3,6-diaza-5-(4-aminobutyl)-4,7-dioxononanoate hydrochloride (26)
This was prepared by general procedure D using 17 (70 mg, 0.12 mmol) giving 26 as a solid (0.050 g, 80% 
Methyl (2S,5R)-2-allyl-10-(N-allyl-1H-indol-3-yl)-3,6-diaza-5-(4-aminobutyl)-4,7-dioxodecanoate hydrochloride (27)
This was prepared by general procedure D using 18 (0.070 g, 0.12 mmol) giving 27 as a solid (0.030 g, 47% 
